Kayne Anderson Rudnick Investment Management LLC Grows Stock Holdings in Exponent, Inc. (NASDAQ:EXPO)

Kayne Anderson Rudnick Investment Management LLC lifted its position in Exponent, Inc. (NASDAQ:EXPO) by 6.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,640,600 shares of the business services provider’s stock after buying an additional 284,179 shares during the quarter. Kayne Anderson Rudnick Investment Management LLC owned approximately 9.15% of Exponent worth $441,414,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. GAMMA Investing LLC lifted its position in shares of Exponent by 67.7% during the second quarter. GAMMA Investing LLC now owns 379 shares of the business services provider’s stock worth $36,000 after purchasing an additional 153 shares in the last quarter. Benjamin F. Edwards & Company Inc. lifted its holdings in Exponent by 866.0% during the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 512 shares of the business services provider’s stock worth $42,000 after buying an additional 459 shares in the last quarter. Whittier Trust Co. of Nevada Inc. boosted its position in Exponent by 166.5% in the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 517 shares of the business services provider’s stock valued at $49,000 after buying an additional 323 shares during the period. Janiczek Wealth Management LLC grew its stake in shares of Exponent by 293.7% in the first quarter. Janiczek Wealth Management LLC now owns 626 shares of the business services provider’s stock worth $52,000 after acquiring an additional 467 shares in the last quarter. Finally, Principal Securities Inc. purchased a new stake in shares of Exponent during the fourth quarter worth $69,000. Institutional investors and hedge funds own 92.37% of the company’s stock.

Insider Activity

In related news, VP John Pye sold 3,956 shares of the business’s stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $105.00, for a total transaction of $415,380.00. Following the completion of the sale, the vice president now owns 28,422 shares in the company, valued at $2,984,310. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 2.10% of the company’s stock.

Exponent Stock Down 0.9 %

Shares of NASDAQ:EXPO opened at $110.77 on Friday. Exponent, Inc. has a fifty-two week low of $64.61 and a fifty-two week high of $113.00. The firm’s 50 day moving average price is $105.37 and its 200 day moving average price is $94.56. The stock has a market cap of $5.62 billion, a price-to-earnings ratio of 55.94 and a beta of 0.66.

Exponent (NASDAQ:EXPO) last announced its quarterly earnings data on Thursday, July 25th. The business services provider reported $0.57 EPS for the quarter, beating analysts’ consensus estimates of $0.50 by $0.07. The company had revenue of $132.43 million for the quarter, compared to the consensus estimate of $130.83 million. Exponent had a net margin of 19.35% and a return on equity of 28.39%. The company’s quarterly revenue was up 2.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.50 EPS. On average, equities analysts anticipate that Exponent, Inc. will post 2.04 EPS for the current year.

Exponent Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 20th. Stockholders of record on Friday, September 6th were given a dividend of $0.28 per share. The ex-dividend date of this dividend was Friday, September 6th. This represents a $1.12 annualized dividend and a dividend yield of 1.01%. Exponent’s dividend payout ratio is currently 56.57%.

Analysts Set New Price Targets

Separately, Truist Financial reiterated a “buy” rating and issued a $120.00 target price (up from $100.00) on shares of Exponent in a report on Friday, July 26th.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.